This year is the 50th Anniversary of the American Academy of Otolaryngic Allergy (AAOA). now our second largest subspecialty organization, with 1871 members and for which Otolaryngology-Head and Neck Surgery is the official JOURNAL. The AAOA was founded as the American Society of Ophthalmologic and Otolaryngologic Allergy in 1941. Its first president was Dr. French Hansel, an otolaryngologist who had published a popular book on "Allergy of the Nose and Paranasal Sinuses" in 1936 and was a former president of the American College of Allergists. I He asserted that sensitivities vary between patients to the same allergen and within a patient to different allergens, and that each sensitivity should be treated individually.
Dr. Herbert Rinkel, an internist practicing in Kansas City, observed Dr. Hansel's techniques, but, instead of using Hansel's 1: 10 fold serial allergen dilution for quantifying patient sensitivities, adopted a more sensitive 1: 5 system. The Food and Drug Administration now uses a 1: 3 titration for extract standardization and research, though it is impractical in clinical settings."
The advantage of titration is that it quantitates the sensitivities of each patient to individual allergens, establishing a safe dose for initiating immunotherapy. Less sensitive patients can frequently be started on immunotherapy preparations that contain more allergen than traditional regimens and, hence, more rapidly reach therapeutic levels.
The first intensive postgraduate courses in allergy management for the otolaryngologist were begun in 1952 by Dr. Rinkel, culminating in a four-article series 
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in the Archives of Otolaryngology' in 1962 Otolaryngology' in -1963 . In them, he elucidated problems in the interpretation of skin test responses and defined "optimum dose," now called "symptom-relieving," immunotherapy as the dose for any individual allergen that gives the best relief with fewest side effects. This dose was found to vary, depending on the antigen and patient, and was frequently less than the traditional "maximum dose" (i.e., 0.5 cc of a 1:50 w/v, unless a lesser amount elicits local or systemic reactions-a common problem with pollens)." Recent research has verified that "blocking antibody" production and clinical responses commonly occur at allergen treatment concentrations much less than the "maximum dose," obviating unnecessary dose escalation and adverse reactions.v' Drs. Hansel and Rinkel, with only rudimentary immunologic tests (e.g., Prausnitz-Kustner reaction, since IgE was not discovered until 1966), depended on keen observation of patients, Rinkel stating that "the moment one ceases to be intrigued by the probable cause of unsatisfactory results, he will also cease to progress, '" As warranted by scientific advances, the AAOA had modified some techniques its early leaders derived from clinical observation, but many concepts remain, such as cyclic food sensitivity and its contribution to allergy symptom production. So does the I :5 antigen dilution test technique. With the # I dilution set at I: 100 w / v, it has excellent correlation with the Fadal/Nalebuff" scoring system of in vitro assays, which are less painful and time-consuming, but currently a bit more expensive alternatives for the diagnosis of inhalant sensitivities. U. 4.5 Resident instruction in otolaryngic allergy is mandated by the American Board of Otolaryngology (ABO) and the Accreditation Council for Graduate Medical Education, which require "knowledge, skill, and understanding" in immunology and allergy "as they relate to the head and neck. "I, This must be applied to all 352 EDITORIAl.
trainees if we are to maintain our credibility in regional allergy, much as we do in regional plastic surgery and for which the American Academy of Facial Plastic and Reconstructive Surgery has resident instruction guidelines. The AAOA also has established resident instruction parameters for a very basic regional allergy knowledge." As with other subspecialties, mastery requires a fellowship or continuing education courses and clinical experience.
The didactic resident instruction can consist of the AAOA "Basic Course" (a standardized 5-day course with tuition reduced for residents), the AAOA Home Study Course (34 hours of CME, similar to the American Academy of Otolaryngology-Head and Neck Surgery Home Study Course), or a lecture series that could contain the AAO-HNS videotapes on skin and in vitro testing, the AAOA Skin Endpoint Titration Manual, and cover the following topics:
I. basic immunology (immunoglobulins, Gell and Coombs reactions, transplantation, and tumor immunology) 2. common allergens impacting on the head and neck (inhalants / foods / chemicals) 3. allergic disorders of the head and neck (external otitis, otitis media, vertigo, headache, rhinitis/ sinusitis, pharyngitis, laryngitis, tracheobronchitis, etc.) 4. diagnosis of otolaryngic allergies (history and physical examination; inhalants-skin titration/RAST; foods-elimination diet/oral challenge/ skin testing) 5. treatment (inhalant allergens-avoidance/drugs/ immunotherapy; food allergens-avoidance / rotary; chemical allergens-avoidance) 6. pharmacotherapy for allergy (decongestants, antihistamines, steroids, eromolyn) 7. integrating regional allergy management and related surgery into an otolaryngology-head and neck surgery practice. The trainee should spend at least 2 weeks in an allergy practice, with closely supervised "hands on" experience in skin testing and preparation of the initial treatment sets on at least four patients who are selected for a strong history of multiseasonal inhalant allergy, verified by an in vitro screen. At this basic level of evaluation, patients with asthma, eczema, or a history of anaphylactoid reactions should be excluded.
The total demand on resident time for the didactic instruction, videotapes/required reading, and patient evaluations is 3 weeks, or about 120 hours. Given the importance of regional allergy management to the field of otolaryngology-head and neck surgery, this should be considered the minimum effort during the 5 or more years of postgraduate training required by the American
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Board of Otolaryngology. Exposure to the lecture series and clinical evaluations should occur during the first or second year of specialty training, so residents recognize allergic disorders in their clinical rotations and can observe patient responses to treatment, learning to deal with co-seasonal variations, concomitant sensitivities, therapeutic failures, adverse reactions, and the like. The AAOA also highly recommends that residents attend its Annual Scientific Meeting, for which registration fees are waived and 45 residents receive travel grants. Postresidency fellowships with stipend support are established, and preference is given to applicants with teaching aspirations.
Membership in the AAOA is open to AAO-HNS fellows, but the criteria for full AAOA Fellowship are as follows: Board certification in otolaryngology, 90 hours of AMA-approved CME credit in otolaryngic allergy within a 5-year period, case reviews from the applicants' practice, and successful completion of a 6-hour written and oral examination (pass rate similar to that for ABO certification).
It is unfortunate that many practicing regional allergy have had to obtain their didactic training in post-residency courses and their clinical experience in an AAOA mini-fellowship.' The AAOA and training program directors must work together to improve this, and this is the reason for the AAOA "Basic" and Home Study Courses, and videotapes developed with the AAO-HNS. A healthy future for regional allergy management by otolaryngologists-head and neck surgeons must not depend solely on postgraduate education but also on our residents acquiring basic skills in this subspecialty. Remember, approximately 20% of Americans have hypersensitivity disease and the paranasal region is the principal target, for which otolaryngologists are best trained to deal with sequelae such as polyposis, sinusitis, and otitis. For patients with perennial symptoms, we should be able to offer more than year-round medication and / or periodic surgery.
